Fulvestrant, Palbociclib, and Trastuzumab
About
Membership operator: AND
Therapies: 3
Therapies
Therapeutic response
Precision oncology relationships for therapeutic response involving this therapy group.
Organizations
Biomarkers
Cancer types
Therapies
| Organizations | Biomarkers | Cancer types | Therapies | |
|---|---|---|---|---|
| FDA (2) | ER positive, HER2-positive | Invasive Breast Carcinoma | Fulvestrant, Palbociclib, Trastuzumab | |
| FDA (2) | HER2-positive, PR positive | Invasive Breast Carcinoma | Fulvestrant, Palbociclib, Trastuzumab |